Boothbay Fund Management’s Intelligent Medicine Acquisition Corp. Warrant IQMDW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-15,746
Closed -$162K 2604
2023
Q1
$162K Hold
15,746
﹤0.01% 1807
2022
Q4
$162K Hold
15,746
﹤0.01% 1669
2022
Q3
$159K Hold
15,746
﹤0.01% 1932
2022
Q2
$158K Hold
15,746
﹤0.01% 1853
2022
Q1
$157K Buy
+15,746
New +$5.74K ﹤0.01% 1973

Boothbay Fund Management's IQMDW Position: Q2 2023 in Review

Boothbay Fund Management sold out of Intelligent Medicine Acquisition Corp. Warrant (IQMDW) in Q2 2023, closing a stake of 15,746 shares — an estimated $162K sold.

Boothbay Fund Management first reported a position in IQMDW in Q1 2022 and held it in 5 quarters. The position peaked at $162K in Q1 2023. 0 funds tracked by Wall St. Rank hold IQMDW as of Q2 2023.

  • Boothbay Fund Management reported no remaining Intelligent Medicine Acquisition Corp. Warrant position as of Q2 2023 after selling out during the quarter.
  • Boothbay Fund Management sold 15,746 Intelligent Medicine Acquisition Corp. Warrant shares in Q2 2023, an estimated $162K.
  • Boothbay Fund Management first reported a position in Intelligent Medicine Acquisition Corp. Warrant in Q1 2022 and held it in 5 quarters.
  • Boothbay Fund Management's Intelligent Medicine Acquisition Corp. Warrant position peaked at $162K in Q1 2023.
  • 0 funds tracked by Wall St. Rank held Intelligent Medicine Acquisition Corp. Warrant as of Q2 2023.

Based on Boothbay Fund Management's 13F filing for Q2 2023, filed 14 Aug 2023.